PT2846805T - Treatment of addiction and impulse-control disorders using pde7 inhibitors - Google Patents
Treatment of addiction and impulse-control disorders using pde7 inhibitorsInfo
- Publication number
- PT2846805T PT2846805T PT13793319T PT13793319T PT2846805T PT 2846805 T PT2846805 T PT 2846805T PT 13793319 T PT13793319 T PT 13793319T PT 13793319 T PT13793319 T PT 13793319T PT 2846805 T PT2846805 T PT 2846805T
- Authority
- PT
- Portugal
- Prior art keywords
- addiction
- impulse
- treatment
- control disorders
- pde7 inhibitors
- Prior art date
Links
- 206010012335 Dependence Diseases 0.000 title 1
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 title 1
- 208000030990 Impulse-control disease Diseases 0.000 title 1
- 229940123304 Phosphodiesterase 7 inhibitor Drugs 0.000 title 1
- 239000002606 phosphodiesterase VII inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261643611P | 2012-05-07 | 2012-05-07 | |
| US13/835,607 US9220715B2 (en) | 2010-11-08 | 2013-03-15 | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2846805T true PT2846805T (en) | 2019-02-27 |
Family
ID=55442549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT13793319T PT2846805T (en) | 2012-05-07 | 2013-05-07 | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
Country Status (11)
| Country | Link |
|---|---|
| JP (4) | JP2016138137A (en) |
| CY (1) | CY1121275T1 (en) |
| DK (1) | DK2846805T3 (en) |
| ES (1) | ES2711949T3 (en) |
| HK (1) | HK1208373A1 (en) |
| HR (1) | HRP20190279T1 (en) |
| HU (1) | HUE043518T2 (en) |
| LT (1) | LT2846805T (en) |
| NZ (1) | NZ628130A (en) |
| PT (1) | PT2846805T (en) |
| RU (1) | RU2665134C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4393882A1 (en) | 2021-08-27 | 2024-07-03 | Sumitomo Metal Mining Co., Ltd. | Infrared curable ink composition, infrared cured product and method for producing infrared cured product |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10148233A1 (en) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Compounds to reduce excessive food intake |
| JP5411504B2 (en) * | 2005-09-26 | 2014-02-12 | メディシノバ， インコーポレイテッド | Use of ibudilast to treat drug and behavioral addiction |
| US20080260643A1 (en) * | 2007-03-27 | 2008-10-23 | Omeros Corporation | Use of pde7 inhibitors for the treatment of movement disorders |
| US8637528B2 (en) * | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| EP3053440B1 (en) * | 2007-04-11 | 2020-08-12 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
-
2013
- 2013-05-07 NZ NZ628130A patent/NZ628130A/en unknown
- 2013-05-07 RU RU2014149192A patent/RU2665134C2/en active
- 2013-05-07 PT PT13793319T patent/PT2846805T/en unknown
- 2013-05-07 HU HUE13793319A patent/HUE043518T2/en unknown
- 2013-05-07 LT LTEP13793319.8T patent/LT2846805T/en unknown
- 2013-05-07 DK DK13793319.8T patent/DK2846805T3/en active
- 2013-05-07 ES ES13793319T patent/ES2711949T3/en active Active
-
2015
- 2015-09-18 HK HK15109162.6A patent/HK1208373A1/en unknown
-
2016
- 2016-05-06 JP JP2016092956A patent/JP2016138137A/en not_active Withdrawn
-
2017
- 2017-07-10 JP JP2017134611A patent/JP6963431B2/en active Active
-
2019
- 2019-02-12 HR HRP20190279TT patent/HRP20190279T1/en unknown
- 2019-02-20 CY CY20191100214T patent/CY1121275T1/en unknown
- 2019-06-06 JP JP2019106083A patent/JP2019142980A/en active Pending
-
2021
- 2021-06-16 JP JP2021100157A patent/JP2021138766A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUE043518T2 (en) | 2019-08-28 |
| HRP20190279T1 (en) | 2019-04-05 |
| RU2014149192A (en) | 2016-07-10 |
| HK1208373A1 (en) | 2016-03-04 |
| CY1121275T1 (en) | 2020-05-29 |
| LT2846805T (en) | 2019-02-25 |
| JP2019142980A (en) | 2019-08-29 |
| JP2021138766A (en) | 2021-09-16 |
| ES2711949T3 (en) | 2019-05-08 |
| RU2665134C2 (en) | 2018-08-28 |
| NZ628130A (en) | 2017-02-24 |
| DK2846805T3 (en) | 2019-03-18 |
| JP6963431B2 (en) | 2021-11-10 |
| JP2016138137A (en) | 2016-08-04 |
| JP2017171691A (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261768B (en) | Devices and methods for the treatment of tissue | |
| EP2640395A4 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
| HRP20171352T1 (en) | Wnt antagonists and methods of treatment | |
| HK1205938A1 (en) | Inhibitors of human ezh2, and methods of use thereof ezh2 | |
| EP2887805A4 (en) | Compounds and methods for treatment of hypertension | |
| SG11201504022RA (en) | Glutamase inhibitors and method of use | |
| HK1207968A1 (en) | Usp30 inhibitors and methods of use usp30 | |
| IL280144A (en) | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms | |
| EP2844271A4 (en) | A method of treatment and agents useful for same | |
| GB201217296D0 (en) | Method of treatment and/or prevention | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| EP2852397A4 (en) | Huwentoxin-iv variants and methods of use | |
| HK1206282A1 (en) | Tfpi inhibitors and methods of use tfpi | |
| EP2694079A4 (en) | Polymers and methods for the treatment of pain | |
| EP2825173A4 (en) | Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies | |
| ZA201501503B (en) | Bio-inoculant and use thereof for treatment of effluents | |
| EP2681209A4 (en) | Compounds and methods for the treatment of pain and other disorders | |
| EP2846805A4 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
| HRP20190279T1 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
| EP2825184A4 (en) | Compositions and methods for treatment of pain | |
| GB201101688D0 (en) | Treatment of porous structire and device therefor |